78155-74-5

Basic information

• Product Name: METHYL 5-BROMO-1H-INDAZOLE-3-CARBOXYLATE
• Synonyms: METHYL 5-BROMO-1H-INDAZOLE-3-CARBOXYLATE;Methyl 5-bromo-1H-indazol...;5-Bromo-3-(methoxycarbonyl)-1H-indazole;5-Bromo-1H-indazole-3-carboxylic acid methyl ester;1H-Indazole-3-carboxylicacid,5-broMo-,Methylester
• CAS NO: 78155-74-5
• Molecular Formula: C₉H₇BrN₂O₂
• Molecular Weight: 255.07
• Mol File: 78155-74-5.mol
• Article Data: 16

Chemical Properties

• Melting Point: 208-210℃
• Boiling Point: 399.7 °C at 760 mmHg
• Flash Point: 195.5 °C
• Appearance: /
• Density: 1.709
• Vapor Pressure: 1.35E-06mmHg at 25°C
• Refractive Index: 1.675
• Storage Temp.: 2-8°C
• PKA: 10.67±0.40(Predicted)
• CAS DataBase Reference: METHYL 5-BROMO-1H-INDAZOLE-3-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 5-BROMO-1H-INDAZOLE-3-CARBOXYLATE(78155-74-5)
• EPA Substance Registry System: METHYL 5-BROMO-1H-INDAZOLE-3-CARBOXYLATE(78155-74-5)

Safety Data

• Hazardous Substances Data: 78155-74-5(Hazardous Substances Data)

Usage

General Description

Methyl 5-bromo-1H-indazole-3-carboxylate is a chemical compound with the molecular formula C9H7BrN2O2. It is a derivative of indazole, a heterocyclic aromatic organic compound. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has potential applications in the development of new drugs and pesticides due to its structural properties and reactivity. Methyl 5-bromo-1H-indazole-3-carboxylate is also used in various research and laboratory experiments as a building block for the synthesis of other organic compounds.

InChI:InChI=1/C9H7BrN2O2/c1-14-9(13)8-6-4-5(10)2-3-7(6)11-12-8/h2-4H,1H3,(H,11,12)

Upstream product

• 87-48-9 5-Bromo-1H-indole-2,3-dione 
• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 459133-66-5 5-bromo-3-iodo-1H-indazole 
• 4498-67-3 1H-Indazole-3-carboxylic acid 
• 1077-94-7 5-bromobenzopyrazole-3-carboxylic acid 
• 43120-28-1 methyl 1H-indazole-3-carboxylate 

Downstream Products

• 705264-93-3 (5-bromo-1H-indazol-3-yl)methanol 
• 1363381-41-2 5-bromo-1-methyl-1H-indazole-3-carboxylic acid methyl ester 
• 1630906-74-9 methyl 5-bromo-2-methyl-2H-indazole-3-carboxylate 
• 1448314-52-0 5-bromo-1-(3-methylbenzoyl)-1H-indazole-3-carboxylic acid methyl ester 
• 1448314-53-1 5-bromo-1-(3-methoxybenzoyl)-1H-indazole-3-carboxylic acid methyl ester 

Relevant articles and documents

Heteroaromatic ring compound and application thereof

The invention relates to a heteroaromatic ring compound and application thereof. Specifically, the invention provides a compound shown as a formula I, or an optical isomer or raceme thereof, or a pharmaceutically acceptable salt thereof. The compound prov

INDAZOLE CONTAINING MACROCYCLES AND THERAPEUTIC USES THEREOF

Indazole macrocycle compounds of formula (I) for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole macrocycle compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states. Formula (I)

Indazol-carboxamide-pyridinone derivatives as well as preparation method and applications thereof

The invention belongs to the field of chemical medicine preparation, and concretely relates to indazol-carboxamide-pyridinone derivatives, a preparation method and applications thereof. The inventionprovides the indazol-carboxamide-pyridinone derivatives, and a structure is represented by a formula I. The present invention also provides the preparation method and the applications of the above indazol-carboxamide-pyridinone derivatives. The indazol-carboxamide-pyridinone derivatives provided by the invention are novel compounds obtained on the basis of a large number of screening, inhibit EZH2activity, and provide a novel selection for development and application of medicines for resisting tumors and autoimmune diseases.